CAMMS EXT · CAMMS03409

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

An extension protocol for patients with multiple sclerosis who participated in Genzyme-sponsored alemtuzumab studies. EudraCT: 2009-010788-18.

Sponsor: GENZYME

Phase: III

Area: Neuroimmunology